Geneoscopy's ColoSense® Test Included as a Preferred Option in the American Cancer Society Colorectal Cancer Screening Guidelines Update

ST. LOUIS--(BUSINESS WIRE)-- #ACSGuidelines--Geneoscopy’s ColoSense® is now an American Cancer Society-preferred at-home RNA test for colorectal cancer screening in average-risk adults aged 45+.